Once again, QS/1 is leading the way to help you make the transition from the current version of the National Council for Prescription Drug Programs (NCPDP) SCRIPT standard to the new one as smooth as possible. Pharmacies and prescribers that transmit electronic prescriptions have a little more than a year to convert to the new version. Currently, pharmacies and prescribers that wish to prescribe electronically must transmit those e-prescriptions using the SCRIPT Standard version 10.6. On January 1, 2020, transmissions must be made using the New SCRIPT Standard version 2017071.
News: Industry News
The year 2017 and early 2018 have been quite a whirlwind for the pharmacy industry. In terms of market performance, dollar growth remains in the low, single digits, following the Hepatitis C bubble in 2014 and 2015.
When the Meaningful Use process started, practices started being more diligent in collecting Business Associate Agreements from all their contractors who had access to their software.
Based on a past study, overdoses from prescription drugs were greater than those involving heroin and cocaine combined. In 2013, more than 100 people died from opioid overdoses every day. How do we combat prescription drug overdoses, which are the leading cause of accidental deaths in the United States?
Like doctors, nurses and other healthcare providers across the country, pharmacists play a pivotal role in patient care. Unlike those providers, pharmacists are not allowed to charge for their services beyond filling prescriptions. However, that could change if Congress passes a law that would grant provider status to pharmacists.
In late 2015, QS/1 embarked on a new chapter in its long and distinguished history in the pharmacy industry. The Company released a new pharmacy management system, SharpRx®, a new logo and a redesigned website. A new vice president of Marketing was hired in November and several internal staff positions were realigned as QS/1 heads confidently into the future of pharmacy.
"The pace of change in pharmacy technology continues to accelerate. New frontiers range from wearables to social media. Embracing change, while engaging patients, is an ongoing concern. Chain Drug Review asked industry executives to look at where pharmacy technology is headed. Representing retailers are... ” — Chain Drug Review/January 18, 2016
Patients have long listed convenience as one of the top three factors when selecting a pharmacy. This is evident in today’s market as millennials and baby boomers continue to rely more on mobile technology to go about their daily tasks. Community pharmacy has always been the leader in providing customer service, but it often lags behind in adopting new retail technologies that can provide more convenience to its patients.
Though much attention is given to changes that occur at the federal level, state-level policy is where the bulk of pharmacy is regulated. In 2015, state policymakers introduced and enacted legislation affecting the profession of pharmacy on many levels.
A few members of the group of market analysts who helped steer the direction of our products over the past several years have retired. Those vacancies have been filled, and we’d like to introduce you to our current team.